Cambrian Genomics, a US-based developer of DNA-printing technology, has secured $10m in a funding round that included Yammer co-founder Adam Pisoni and Cloudera founder Jeff Hammerbacher, according to VentureBeat.
Seed-stage venture capital firm Draper Associates also participated. In total, 127 investors invested in the round, but the company is not disclosing who led the round, or the identity of all its investors.
Cambrian Genomics previously secured $28,000 when it took part in the six-month Alchemist Accelerator, from which it graduated in January 2013.
The accelerator is backed by networking equipment specialist Cisco Systems, engineering conglomerate Siemens, cloud computing company Salesforce.com, SAP Ventures, the corporate venturing unit of software company SAP, and VC firms Draper Fisher Jurvetson, Foundation Capital, Khosla Ventures and US Venture Partners.
Cambrian Genomics has partnered with pharmaceutical company GlaxoSmithKline to print DNA for drug development and is working on formalising a similar agreement with pharmaceutical company Roche.
The company is also trying to attract industrial chemical and agricultural industries, for which it could produce custom-made seeds.